文献速递关节外科

Medicare的Nursing Home Compare评级能否准确预测初次全关节置换术患者90天并发症、再入院和捆绑费用?

Are Medicare's Nursing Home Compare Ratings Accurate Predictors of 90-Day Complications, Readmission, and Bundle Cost for Patients Undergoing Primary Total Joint Arthroplasty?
PubMed 文献 · J Arthroplasty · 2018-12-08

本研究查询了一个多医院学术健康系统2017年所有出院至专业护理机构(SNF)的初次全关节置换术病例,共488例患者出院至105个SNF;多因素分析显示,NHC总体评级不能预测90天再入院/主要并发症、高于第75百分位的急性后期费用或超过目标价格的90天捆绑费用,但较高的SNF人员配置评级与降低的高于第75百分位90天急性后期费用(OR 0.58;P=0.01)和超过目标价格的90天捆绑费用(OR 0.69;P=0.02)的几率独立相关。

要点

  • NHC总体评级不能预测90天再入院/主要并发症、高于第75百分位的急性后期费用或超过目标价格的捆绑费用。
  • SNC健康检查和质量测量评级也不能预测90天再入院/主要并发症或捆绑费用表现。
  • 较高的SNF人员配置评级与降低的高于第75百分位90天急性后期费用(OR 0.58;P=0.01)和超过目标价格的90天捆绑费用(OR 0.69;P=0.02)的几率独立相关。

核心结论

  • 作者认为,对于本健康系统内的SNF,Medicare的NHC工具不能有效预测90天费用、并发症或再入院。

研究设计与样本

  • 回顾性查询2017年一个多医院学术健康系统中所有出院至SNF的初次全关节置换术病例,从健康记录手工提取人口学、心理社会和临床变量,并收集每个SNF的Medicare NHC评级。
  • 共488例患者出院至105个SNF。

主要发现

  • 多因素分析中,NHC总体评级不能预测90天再入院/主要并发症、高于第75百分位的急性后期费用或超过目标价格的90天捆绑费用。
  • SNF健康检查和SNF质量测量评级也不能预测90天再入院/主要并发症或捆绑费用表现。
  • 较高的SNF人员配置评级与降低的高于第75百分位90天急性后期费用的几率独立相关(OR 0.58;P=0.01)。
  • 较高的SNF人员配置评级与降低的90天捆绑费用超过目标价格的几率独立相关(OR 0.69;P=0.02)。
  • 较高的SNF人员配置评级不能预测90天再入院/并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nursing Home Compare (NHC) ratings, created and maintained by Medicare, are used by both hospitals and consumers to aid in the skilled nursing facility (SNF) selection process. To date, no studies have linked NHC ratings to actual episode-based outcomes. The purpose of this study was to evaluate whether NHC ratings are valid predictors of 90-day complications, readmission, and bundle costs for patients discharged to an SNF after primary total joint arthroplasty (TJA). METHODS: All SNF-discharged primary TJA cases in 2017 at a multihospital academic health system were queried. Demographic, psychosocial, and clinical variables were manually extracted from the health record. Medicare NHC ratings were then collected for each SNF. For patients in the Medicare bundle, postacute and total bundle cost was extracted from claims. RESULTS: Four hundred eighty-eight patients were discharged to a total of 105 unique SNFs. In multivariate analysis, overall NHC rating was not predictive of 90-day readmission/major complications, >75th percentile postacute cost, or 90-day bundle cost exceeding the target price. SNF health inspection and quality measure ratings were also not predictive of 90-day readmission/major complications or bundle performance. A higher SNF staffing rating was independently associated with a decreased odds for >75th percentile 90-day postacute spend (odds ratio, 0.58; P = .01) and a 90-day bundle cost exceeding the target price (odds ratio = 0.69; P = .02) but was similarly not predictive of 90-day readmission/complications. CONCLUSION: Results of our study suggest that Medicare's NHC tool is not a useful predictor of 90-day costs, complications, or readmissions for SNFs within our health system.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Snyder DJ, Kroshus TR, Keswani A, et al. Are Medicare's Nursing Home Compare Ratings Accurate Predictors of 90-Day Complications, Readmission, and Bundle Cost for Patients Undergoing Primary Total Joint Arthroplasty? J Arthroplasty. 2018. PMID: 30630648. doi:10.1016/j.arth.2018.12.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。